Evidence map›Paper›PMID 40910054›Full record

ArticleFrontiers in public health2025

Epidemiology of tuberculosis in Minas Gerais, Brazil, between 2013 and 2023 and the impact of the COVID-19 pandemic.

Renan Clímaco do Bem Braga, Igor Rosa Meurer, Maisah Meyhr D'Carmo Sodré, Luciana Debortoli de Carvalho, Lauro Juliano Marin, Marcelo Silva Silvério, Patrícia Guedes Garcia

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Renan Clímaco do Bem BragaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Igor Rosa MeurerTeaching and Research Management, University Hospital of the Federal University of Juiz de Fora/Brazilian Company of Hospital Services, Juiz de Fora, Brazil.
Maisah Meyhr D'Carmo SodréDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Brazil.
Luciana Debortoli de CarvalhoDepartment of Clinical Medicine, Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Lauro Juliano MarinDepartment of Health, Santa Cruz State University, Ilhéus, Brazil.
Marcelo Silva SilvérioDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Patrícia Guedes GarciaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis (TB), a disease caused by bacteria of the Methods: Based on epidemiological data obtained from the DATASUS platform, spanning the period from 2013 to 2023, the number of cases, the distribution of confirmed cases by sex, race, education, age group, HIV co-infection and presence of comorbidities such as diabetes, and risk factors like smoking and alcoholism were evaluated. Additionally, the municipalities with the highest number of confirmed cases were identified. Results: The research revealed a steady annual rise in TB cases, having the highest number of cases in 2023, with 12.55% of all reported cases. Men between 25 and 54 years of age, with a lower educational level, were the most affected by the disease. Regarding race, the majority of the reported cases were attributed to Brown-skinned people. The co-infection rate involving TB and HIV increased proportionally to the reported cases of TB statewide. Regarding comorbidities and risk factors, diabetes, smoking, and alcoholism composed a large part of the tuberculosis caseload, with alcoholism and smoking being especially related to the male population. Conclusion: The results reinforced the gravity of tuberculosis as a public health challenge, while highlighting the impact of the COVID-19 pandemic on underreporting and the subsequent increase in reported cases of drug resistance involving tuberculosis.

Indexed as

COVID-19TuberculosisAdolescentAdultAgedBrazilChildCoinfectionComorbidityFemaleHIV InfectionsHumansMaleMiddle AgedPandemicsRisk Factorsbacterial drug resistanceCOVID-19epidemiologyMycobacterium tuberculosispublic health surveillancetuberculosisunderreporting

Identifiers

PMID40910054
PMCPMC12405410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.